KELSPRIG Trademark

Trademark Overview

On Wednesday, May 7, 2014, a trademark application was filed for KELSPRIG with the United States Patent and Trademark Office. The USPTO has given the KELSPRIG trademark a serial number of 79147686. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, May 7, 2024. This trademark is owned by Merck KGaA. The KELSPRIG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use in the field of oncology
kelsprig

General Information

Serial Number79147686
Word MarkKELSPRIG
Filing DateWednesday, May 7, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, May 7, 2024
Registration Number4639152
Registration DateTuesday, November 18, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use in the field of oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 4, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, June 5, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, June 10, 2014APPLICATION FILING RECEIPT MAILED
Friday, June 6, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 9, 2014ASSIGNED TO EXAMINER
Monday, June 16, 2014REFUSAL PROCESSED BY MPU
Friday, July 11, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 11, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 11, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 11, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 26, 2014ASSIGNED TO LIE
Thursday, June 12, 2014NON-FINAL ACTION WRITTEN
Friday, June 13, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 16, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 4, 2014REFUSAL PROCESSED BY IB
Tuesday, November 18, 2014REGISTERED-PRINCIPAL REGISTER
Friday, April 17, 2015FINAL DISPOSITION PROCESSED
Friday, May 8, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, November 18, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 4, 2021CANCELLED SECTION 71
Saturday, July 26, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 13, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 2, 2014PUBLISHED FOR OPPOSITION
Tuesday, September 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 18, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 17, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 4, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 8, 2022NEW REPRESENTATIVE AT IB RECEIVED
Monday, June 6, 2022INVALIDATION PROCESSED
Monday, June 6, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, July 18, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, December 2, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, November 29, 2024DEATH OF INTERNATIONAL REGISTRATION

Related Keywords

kelsprig oncology field human preparations pharmaceutical